InsiderClue
← All stocks

Travere Therapeutics, Inc.

TVTX Net selling
CIK 0001438533 #1223 in the set updated 22 Sep 2026
Bought (120 mo)
$89.25K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$129.25M
$14.01M on a plan · $99.79M straight out of an exercise
Sold at will
$15.45M
267 of 431 sales
Net
−$129.16M
−$15.36M against sales at will

By person

21 insiders · 433 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Dube Eric M
CHIEF EXECUTIVE OFFICER
—
$46.63M (53) scheduled
−$46.63M
432,886
0.4592%
$28.12M
—
Heerma Peter
EVP, CHIEF COMMERCIAL OFFICER
—
$19.90M (35) scheduled
−$19.90M
117,066
0.1242%
$7.60M
+865.6%
ROTE WILLIAM E.
Chief Research Officer
—
$18.35M (59) scheduled
−$18.35M
98,197
0.1042%
$6.38M
+826.3%
REED ELIZABETH E
Chief Legal Officer and GC
—
$9.27M (70) scheduled
−$9.27M
105,389
0.1118%
$6.85M
+6,088%
ASELAGE STEVE
Director
$89.25K (1)
$7.30M (40) scheduled
−$7.21M
166,419
0.1766%
$10.81M
−50.4%
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
—
$6.30M (30) scheduled
−$6.30M
42,353
0.0449%
$2.75M
+40.5%
Inrig Jula
EVP, Head of R&D & CMO
—
$5.51M (28) scheduled
−$5.51M
100,491
0.1066%
$6.53M
—
Cline Christopher R.
CHIEF FINANCIAL OFFICER
—
$4.96M (32) scheduled
−$4.96M
87,508
0.0928%
$5.68M
+204.7%
Baynes Roy D.
Director
—
$3.09M (8) scheduled
−$3.09M
41,500
0.0440%
$2.70M
+937.5%
Meckler Jeffrey A
Director
—
$2.27M (6) scheduled
−$2.27M
91,500
0.0971%
$5.94M
+69.4%
Clague Laura
Chief Financial Officer
—
$1.93M (35)
−$1.93M
35,655
0.0378%
$2.32M
—
LYONS GARY A
Director
—
$1.55M (8) scheduled
−$1.55M
61,500
0.0652%
$3.99M
+156.3%
Coughlin Timothy
Director
—
$1.27M (3) scheduled
−$1.27M
56,250
0.0597%
$3.65M
+155.7%
McFarlane Neil F.
Chief Operating Officer
—
$552.56K (7)
−$552.56K
26,988
0.0286%
$1.75M
+56.1%
Rosenberg Noah L.
Chief Medical Officer
—
$366.78K (17)
−$366.78K
47,614
0.0505%
$3.09M
+2,185%
Squarer Ron
Director
—
—
—
39,375
0.0418%
$2.56M
—
Orwin John A
Director
—
—
—
39,375
0.0418%
$2.56M
—
Poole Sandra
Director
—
—
—
34,000
0.0361%
$2.21M
—
Bruhn Suzanne Louise
Director
—
—
—
32,750
0.0347%
$2.13M
—
Williams Brinkley Ruth
Director
—
—
—
29,750
0.0316%
$1.93M
—
KOZARICH JOHN W
Director
—
—
—
29,000
0.0308%
$1.88M
+31.8%

Individual transactions

89
Insider
Date
Role
Action
Shares
Price
Amount
Dube Eric M
17 Sep 2026
CHIEF EXECUTIVE OFFICER
Sold after exercise
6,802
$64.95
$441.80K
Dube Eric M
17 Sep 2026
CHIEF EXECUTIVE OFFICER
Sold after exercise
101,691
$64.59
$6.57M
Heerma Peter
17 Sep 2026
EVP, CHIEF COMMERCIAL OFFICER
Sold after exercise
8,282
$65.07
$538.92K
ROTE WILLIAM E.
16 Sep 2026
Chief Research Officer
Sold after exercise
47,746
$63.61
$3.04M
ROTE WILLIAM E.
16 Sep 2026
Chief Research Officer
Sold after exercise
65,104
$63.12
$4.11M
Dube Eric M
16 Sep 2026
CHIEF EXECUTIVE OFFICER
Sold after exercise
96,125
$63.64
$6.12M
Dube Eric M
16 Sep 2026
CHIEF EXECUTIVE OFFICER
Sold after exercise
99,716
$63.26
$6.31M
Heerma Peter
16 Sep 2026
EVP, CHIEF COMMERCIAL OFFICER
Sold after exercise
79,113
$63.65
$5.04M
Heerma Peter
16 Sep 2026
EVP, CHIEF COMMERCIAL OFFICER
Sold after exercise
93,604
$63.25
$5.92M
ROTE WILLIAM E.
15 Sep 2026
Chief Research Officer
Sold after exercise
270
$65.31
$17.63K
ROTE WILLIAM E.
15 Sep 2026
Chief Research Officer
Sold after exercise
3,000
$63.65
$190.95K
ROTE WILLIAM E.
15 Sep 2026
Chief Research Officer
Sold after exercise
29,021
$62.66
$1.82M
ROTE WILLIAM E.
15 Sep 2026
Chief Research Officer
Sold after exercise
63,907
$61.99
$3.96M
Calvin Sandra
15 Sep 2026
SVP, CHIEF ACCOUNTING OFFICER
Sold after exercise
300
$63.66
$19.10K
Calvin Sandra
15 Sep 2026
SVP, CHIEF ACCOUNTING OFFICER
Sold after exercise
800
$62.85
$50.28K
Calvin Sandra
15 Sep 2026
SVP, CHIEF ACCOUNTING OFFICER
Sold after exercise
4,275
$62.14
$265.63K
Cline Christopher R.
15 Sep 2026
CHIEF FINANCIAL OFFICER
Sold after exercise
400
$65.31
$26.12K
Cline Christopher R.
15 Sep 2026
CHIEF FINANCIAL OFFICER
Sold after exercise
1,900
$63.69
$121.00K
Cline Christopher R.
15 Sep 2026
CHIEF FINANCIAL OFFICER
Sold after exercise
20,735
$62.61
$1.30M
Cline Christopher R.
15 Sep 2026
CHIEF FINANCIAL OFFICER
Sold after exercise
27,473
$62.00
$1.70M
Dube Eric M
15 Sep 2026
CHIEF EXECUTIVE OFFICER
Sold after exercise
270
$65.31
$17.63K
Dube Eric M
15 Sep 2026
CHIEF EXECUTIVE OFFICER
Sold after exercise
3,102
$63.64
$197.42K
Dube Eric M
15 Sep 2026
CHIEF EXECUTIVE OFFICER
Sold after exercise
28,796
$62.66
$1.80M
Dube Eric M
15 Sep 2026
CHIEF EXECUTIVE OFFICER
Sold after exercise
63,498
$61.99
$3.94M
REED ELIZABETH E
15 Sep 2026
Chief Legal Officer and GC
Sold after exercise
300
$65.31
$19.59K
REED ELIZABETH E
15 Sep 2026
Chief Legal Officer and GC
Sold after exercise
1,400
$63.69
$89.17K
REED ELIZABETH E
15 Sep 2026
Chief Legal Officer and GC
Sold after exercise
13,874
$62.63
$868.96K
REED ELIZABETH E
15 Sep 2026
Chief Legal Officer and GC
Sold after exercise
21,926
$62.03
$1.36M
Inrig Jula
15 Sep 2026
EVP, Head of R&D & CMO
Sold after exercise
400
$65.31
$26.12K
Inrig Jula
15 Sep 2026
EVP, Head of R&D & CMO
Sold after exercise
1,600
$63.69
$101.90K
Inrig Jula
15 Sep 2026
EVP, Head of R&D & CMO
Sold after exercise
17,284
$62.62
$1.08M
Inrig Jula
15 Sep 2026
EVP, Head of R&D & CMO
Sold after exercise
25,390
$62.02
$1.57M
Heerma Peter
15 Sep 2026
EVP, CHIEF COMMERCIAL OFFICER
Sold after exercise
1,431
$65.31
$93.46K
Heerma Peter
15 Sep 2026
EVP, CHIEF COMMERCIAL OFFICER
Sold after exercise
1,400
$63.65
$89.11K
Heerma Peter
15 Sep 2026
EVP, CHIEF COMMERCIAL OFFICER
Sold after exercise
27,421
$62.59
$1.72M
Heerma Peter
15 Sep 2026
EVP, CHIEF COMMERCIAL OFFICER
Sold after exercise
71,938
$62.05
$4.46M
Meckler Jeffrey A
10 Sep 2026
Director
Sold after exercise
3,100
$68.09
$211.07K
Meckler Jeffrey A
10 Sep 2026
Director
Sold after exercise
14,000
$67.46
$944.49K
Meckler Jeffrey A
10 Sep 2026
Director
Sold after exercise
1,200
$66.15
$79.38K
Meckler Jeffrey A
10 Sep 2026
Director
Sold after exercise
1,700
$65.39
$111.17K
LYONS GARY A
18 Aug 2026
Director
Sold after exercise
900
$63.86
$57.47K
LYONS GARY A
18 Aug 2026
Director
Sold after exercise
4,100
$63.27
$259.39K
LYONS GARY A
17 Aug 2026
Director
Sold after exercise
500
$64.16
$32.08K
LYONS GARY A
17 Aug 2026
Director
Sold after exercise
2,600
$63.50
$165.10K
LYONS GARY A
17 Aug 2026
Director
Sold after exercise
1,900
$62.53
$118.80K
Baynes Roy D.
12 Jun 2026
Director
Sold after exercise
4,500
$50.00
$225.00K
Coughlin Timothy
12 Jun 2026
Director
Sold after exercise
10,000
$50.07
$500.75K
Baynes Roy D.
5 May 2026
Director
Sold after exercise
4,500
$46.65
$209.93K
Inrig Jula
4 May 2026
CHIEF MEDICAL OFFICER
Sold after exercise
20,000
$45.00
$900.00K
REED ELIZABETH E
4 May 2026
Chief Legal Officer and GC
Sold after exercise
20,000
$45.00
$900.00K
Meckler Jeffrey A
4 May 2026
Director
Sold after exercise
8,000
$45.00
$360.00K
Baynes Roy D.
1 May 2026
Director
Sold after exercise
9,750
$44.22
$431.15K
REED ELIZABETH E
14 Apr 2026
Chief Legal Officer and GC
Sold after exercise
7,215
$41.93
$302.52K
REED ELIZABETH E
14 Apr 2026
Chief Legal Officer and GC
Sold after exercise
37,500
$41.07
$1.54M
Calvin Sandra
14 Apr 2026
SVP, CHIEF ACCOUNTING OFFICER
Sold after exercise
21,977
$41.07
$902.60K
Baynes Roy D.
14 Apr 2026
Director
Sold after exercise
6,750
$42.12
$284.31K
Baynes Roy D.
14 Apr 2026
Director
Sold after exercise
26,000
$41.07
$1.07M
LYONS GARY A
14 Apr 2026
Director
Sold after exercise
8,000
$41.07
$328.56K
Baynes Roy D.
6 Apr 2026
Director
Sold after exercise
10,000
$33.00
$330.00K
REED ELIZABETH E
1 Apr 2026
Chief Legal Officer and GC
Sold after exercise
10,000
$30.00
$300.00K
Dube Eric M
1 Apr 2026
CHIEF EXECUTIVE OFFICER
Sold after exercise
25,098
$31.46
$789.58K
Dube Eric M
1 Apr 2026
CHIEF EXECUTIVE OFFICER
Sold after exercise
34,902
$30.55
$1.07M
REED ELIZABETH E
16 Mar 2026
Chief Legal Officer and GC
Sold after exercise
10,000
$28.09
$280.86K
Dube Eric M
20 Feb 2026
CHIEF EXECUTIVE OFFICER
Sold after exercise
60,000
$30.10
$1.81M
REED ELIZABETH E
17 Feb 2026
Chief Legal Officer and GC
Sold after exercise
4,321
$28.26
$122.12K
REED ELIZABETH E
17 Feb 2026
Chief Legal Officer and GC
Sold after exercise
5,679
$27.50
$156.20K
Dube Eric M
27 Jan 2026
CHIEF EXECUTIVE OFFICER
Sold after exercise
51,865
$30.10
$1.56M
Dube Eric M
23 Jan 2026
CHIEF EXECUTIVE OFFICER
Sold after exercise
8,135
$30.01
$244.15K
REED ELIZABETH E
20 Jan 2026
Chief Legal Officer and GC
Sold after exercise
10,000
$27.34
$273.42K
Inrig Jula
24 Dec 2025
CHIEF MEDICAL OFFICER
Sold after exercise
15,000
$42.00
$630.00K
ROTE WILLIAM E.
24 Dec 2025
Chief Research Officer
Sold after exercise
60,000
$40.10
$2.41M
Cline Christopher R.
1 Dec 2025
CHIEF FINANCIAL OFFICER
Sold after exercise
20,000
$35.01
$700.20K
Calvin Sandra
4 Nov 2025
SVP, CHIEF ACCOUNTING OFFICER
Sold after exercise
67,115
$36.00
$2.42M
Coughlin Timothy
31 Oct 2025
Director
Sold after exercise
18,000
$35.03
$630.60K
Dube Eric M
29 Oct 2025
CHIEF EXECUTIVE OFFICER
Sold after exercise
27,128
$30.12
$817.07K
Dube Eric M
28 Oct 2025
CHIEF EXECUTIVE OFFICER
Sold after exercise
92,872
$30.38
$2.82M
REED ELIZABETH E
22 Sep 2025
Chief Legal Officer and GC
Sold after exercise
10,000
$25.00
$250.00K
Calvin Sandra
11 Feb 2025
SVP, CHIEF ACCOUNTING OFFICER
Sold after exercise
9,244
$25.00
$231.10K
Calvin Sandra
11 Feb 2025
SVP, CHIEF ACCOUNTING OFFICER
Sold after exercise
15,000
$25.00
$375.00K
Calvin Sandra
11 Feb 2025
SVP, CHIEF ACCOUNTING OFFICER
Sold after exercise
10,000
$25.00
$250.00K
Calvin Sandra
11 Feb 2025
SVP, CHIEF ACCOUNTING OFFICER
Sold after exercise
10,000
$25.00
$250.00K
Calvin Sandra
11 Feb 2025
SVP, CHIEF ACCOUNTING OFFICER
Sold after exercise
10,000
$25.00
$250.00K
Baynes Roy D.
6 Feb 2025
Director
Sold after exercise
10,000
$22.00
$220.00K
Baynes Roy D.
23 Jan 2025
Director
Sold after exercise
16,000
$20.00
$320.00K
Calvin Sandra
26 Dec 2024
SVP, CHIEF ACCOUNTING OFFICER
Sold after exercise
15,000
$17.22
$258.28K
Calvin Sandra
25 Nov 2024
SVP, CHIEF ACCOUNTING OFFICER
Sold after exercise
12,090
$18.30
$221.26K
LYONS GARY A
4 Oct 2024
Director
Sold after exercise
18,821
$15.15
$285.23K
LYONS GARY A
4 Oct 2024
Director
Sold after exercise
21,179
$14.35
$303.87K
Meckler Jeffrey A
30 Sep 2024
Director
Sold after exercise
40,000
$14.06
$562.32K
Showing 250 of 433 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 423
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 67
Sales straight out of an exercise 97
Sales at will 267
Transactions with no price 0
Shares from compensation/vesting 4,655,938
Sales filed before the plan box existed 219
History held since 2 Sep 2016